Meanwhile, multi-target agonists are of increasing interest to researchers
Alternative medication classes should be considered if GLP-1 therapy proves intolerable: SGLT2 inhibitors (such as dapagliflozin, empagliflozin) for type 2 diabetes, which work via a completely different mechanism and rarely cause gastrointestinal side effects DPP-4 inhibitors (such as sitagliptin, linagliptin), which enhance endogenous GLP-1 activity more gently Metformin remains first-line for type 2 diabetes, though it can also cause gastrointestinal side effects Orlistat for weight management, though this also has gastrointestinal side effects of a different nature For weight management specifically, NICE recommends a comprehensive approach including dietary modification, increased physical activity, and behavioural interventions, with or without pharmacotherapy
We very much look forward to the next steps and seeing the drug tested in two large Phase III clinical trials, Shelly Williamson, the Chair of patient charity IIH UK stated
Welcome packages, free spins, reload deals, and tournaments should come with straightforward eligibility requirements and wagering disclosures, presented in plain language